Setmelanotide
RM-493-012
Phase 3 small_molecule completed
Quick answer
Setmelanotide for Pro-opiomelanocortin (POMC) Deficiency Obesity is a Phase 3 program (small_molecule) at Rhythm Pharmaceuticals Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Rhythm Pharmaceuticals Netherlands B.V.
- Indication
- Pro-opiomelanocortin (POMC) Deficiency Obesity
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed